Antioxidants preserve macrophage phagocytosis of Pseudomonas aeruginosa during hyperoxia

Free Radical Biology and Medicine

Volumn 42, Issue 9, 2007, Pages 1338-1349

  Morrow, Dympna M P ^a,b   Entezari Zaher, Tahereh ^a,b   Romashko III, John ^b   Azghani, Ali O ^c   Javdan, Mohammad ^b   Ulloa, Luis ^b   Miller, Edmund J ^b   Mantell, Lin L ^a,b  

^a ST JOHN'S UNIVERSITY   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

Actin cytoskeleton; Alveolar macrophages; Bacterial infection; Oxidation; Pseudomonas aeruginosa; Ventilator associated pneumonia

Indexed keywords

ACTIN; ANTIOXIDANT; COPPER ZINC SUPEROXIDE DISMUTASE; LIPOPOLYSACCHARIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ACTIN POLYMERIZATION; ANIMAL CELL; ARTICLE; C57BL 6 MOUSE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOSKELETON; HYPEROXIA; KLEBSIELLA PNEUMONIAE; LUNG ALVEOLUS MACROPHAGE; LUNG INJURY; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STATISTICAL ANALYSIS; VENTILATOR ASSOCIATED PNEUMONIA;

ANIMALS; ANTIOXIDANTS; CELL LINE; HYPEROXIA; MACROPHAGES; MACROPHAGES, ALVEOLAR; MICE; PHAGOCYTOSIS; PSEUDOMONAS AERUGINOSA; SUPEROXIDE DISMUTASE;

BACTERIA (MICROORGANISMS); MUS; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 33947495690     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.01.031     Document Type: Article

References (61)

1. Mehta R.M., and Niederman M.S. Nosocomial pneumonia in the intensive care unit: controversies and dilemmas. J. Intens. Care Med. 18 (2003) 175-188
2. Richards M.J., Edwards J.R., Culver D.H., and Gaynes R.P. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit. Care Med. 27 (1999) 887-892
3. Intensive Care Antimicrobial Resistance Epidemiology (ICARE). Surveillance Report, data summary from January 1996 through December 1997: a report from the National Nosocomial Infections Surveillance (NNIS) System. Am. J. Infect. Control. 27 (1999) 279-284
4. Marquette C.H., Copin M.C., Wallet F., Neviere R., Saulnier F., Mathieu D., Durocher A., Ramon P., and Tonnel A.B. Diagnostic tests for pneumonia in ventilated patients: prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard. Am. J. Respir. Crit. Care Med. 151 (1995) 1878-1888
5. Garau J., and Gomez L. Pseudomonas aeruginosa pneumonia. Curr. Opin. Infect. Dis. 16 (2003) 135-143
6. Mantell L.L., Horowitz S., Davis J.M., and Kazzaz J.A. Hyperoxia-induced cell death in the lung-the correlation of apoptosis, necrosis, and inflammation. Ann. N. Y. Acad. Sci. 887 (1999) 171-180
7. Mantell L.L., Kazzaz J.A., Xu J., Palaia T.A., Piedboeuf B., Hall S., Rhodes G.C., Niu G., Fein A.F., and Horowitz S. Unscheduled apoptosis during acute inflammatory lung injury. Cell Death Differ. 4 (1997) 600-607
8. Crapo J.D. Morphologic changes in pulmonary oxygen toxicity. Annu. Rev. Physiol. 48 (1986) 721-731
9. Crapo J.D., Barry B.E., Foscue H.A., and Shelburne J. Structural and biochemical changes in rat lungs occurring during exposures to lethal and adaptive doses of oxygen. Am. Rev. Respir. Dis. 122 (1980) 123-143
10. Waxman A.B., Einarsson O., Seres T., Knickelbein R.G., Warshaw J.B., Johnston R., Homer R.J., and Elias J.A. Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation. J. Clin. Invest. 101 (1998) 1970-1982
11. Barazzone C., and White C.W. Mechanisms of cell injury and death in hyperoxia: role of cytokines and Bcl-2 family proteins. Am. J. Respir. Cell Mol. Biol. 22 (2000) 517-519
12. O'Reilly M.A., Staversky R.J., Finkelstein J.N., and Keng P.C. Activation of the G2 cell cycle checkpoint enhances survival of epithelial cells exposed to hyperoxia. Am. J. Physiol. Lung Cell Mol. Physiol. 284 (2003) L368-L375
13. Lee P.J., Alam J., Wiegand G.W., and Choi A.M. Overexpression of heme oxygenase-1 in human pulmonary epithelial cells results in cell growth arrest and increased resistance to hyperoxia. Proc. Natl. Acad. Sci. USA 93 (1996) 10393-10398
14. Ogunlesi F., Cho C., and McGrath-Morrow S.A. The effect of glutamine on A549 cells exposed to moderate hyperoxia. Biochim. Biophys. Acta 1688 (2004) 112-120
15. Ray P., Devaux Y., Stolz D.B., Yarlagadda M., Watkins S.C., Lu Y., Chen L., Yang X.F., and Ray A. Inducible expression of keratinocyte growth factor (KGF) in mice inhibits lung epithelial cell death induced by hyperoxia. Proc. Natl. Acad. Sci. USA 100 (2003) 6098-6103
16. Li Y., Arita Y., Koo H.C., Davis J.M., and Kazzaz J.A. Inhibition of c-Jun N-terminal kinase pathway improves cell viability in response to oxidant injury. Am. J. Respir. Cell Mol. Biol. 29 (2003) 779-783
17. Ahmad A., Ahmad S., Schneider B.K., Allen C.B., Chang L.Y., and White C.W. Elevated expression of hexokinase II protects human lung epithelial-like A549 cells against oxidative injury. Am. J. Physiol. Lung Cell Mol. Physiol. 283 (2002) L573-L584
18. Ahmad S., Ahmad A., Gerasimovskaya E., Stenmark K.R., Allen C.B., and White C.W. Hypoxia protects human lung microvascular endothelial and epithelial-like cells against oxygen toxicity: role of phosphatidylinositol 3-kinase. Am. J. Respir. Cell Mol. Biol. 28 (2003) 179-187
19. Ahmad S., Ahmad A., Ghosh M., Leslie C.C., and White C.W. Extracellular ATP-mediated signaling for survival in hyperoxia-induced oxidative stress. J. Biol. Chem. 279 (2004) 16317-16325
20. Petrache I., Choi M.E., Otterbein L.E., Chin B.Y., Mantell L.L., Horowitz S., and Choi A.M. Mitogen-activated protein kinase pathway mediates hyperoxia-induced apoptosis in cultured macrophage cells. Am. J. Physiol. 277 (1999) L589-L595
21. Nyunoya T., Powers L.S., Yarovinsky T.O., Butler N.S., Monick M.M., and Hunninghake G.W. Hyperoxia induces macrophage cell cycle arrest by adhesion-dependent induction of p21Cip1 and activation of the retinoblastoma protein. J. Biol. Chem. 278 (2003) 36099-36106
22. Nyunoya T., Monick M.M., Powers L.S., Yarovinsky T.O., and Hunninghake G.W. Macrophages survive hyperoxia via prolonged ERK activation due to phosphatase down-regulation. J. Biol. Chem. 280 (2005) 26295-26302
23. Buccellato L.J., Tso M., Akinci O.I., Chandel N.S., and Budinger G.R. Reactive oxygen species are required for hyperoxia-induced Bax activation and cell death in alveolar epithelial cells. J. Biol. Chem. 279 (2004) 6753-6760
24. Kooguchi K., Hashimoto S., Kobayashi A., Kitamura Y., Kudoh I., Wiener-Kronish J., and Sawa T. Role of alveolar macrophages in initiation and regulation of inflammation in Pseudomonas aeruginosa pneumonia. Infect. Immun. 66 (1998) 3164-3169
25. Baleeiro C.E., Wilcoxen S.E., Morris S.B., Standiford T.J., and Paine III R. Sublethal hyperoxia impairs pulmonary innate immunity. J. Immunol. 171 (2003) 955-963
26. Rister M. Effects of hyperoxia on phagocytosis. Blut 45 (1982) 157-166
27. Raffin T.A., Simon L.M., Braun D., Theodore J., and Robin E.D. Impairment of phagocytosis by moderate hyperoxia (40 to 60 per cent oxygen) in lung macrophages. Lab. Invest. 42 (1980) 622-626
28. Crowell R.E., Hallin G., Heaphy E., and Mold C. Hyperoxic suppression of Fc-gamma receptor-mediated phagocytosis by isolated murine pulmonary macrophages. Am. J. Respir. Cell Mol. Biol. 12 (1995) 190-195
29. O'Reilly P.J., Hickman-Davis J.M., Davis I.C., and Matalon S. Hyperoxia impairs antibacterial function of macrophages through effects on actin. Am. J. Respir. Cell Mol. Biol. 28 (2003) 443-450
30. Freeman B.A., and Crapo J.D. Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. J. Biol. Chem. 256 (1981) 10986-10992
31. Michiels C., Raes M., Toussaint O., and Remacle J. Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic. Biol. Med. 17 (1994) 235-248
32. Pietarinen P., Raivio K., Devlin R.B., Crapo J.D., Chang L.Y., and Kinnula V.L. Catalase and glutathione reductase protection of human alveolar macrophages during oxidant exposure in vitro. Am. J. Respir. Cell Mol. Biol. 13 (1995) 434-441
33. Terry J.M., Pina S.E., and Mattingly S.J. Role of energy metabolism in conversion of nonmucoid Pseudomonas aeruginosa to the mucoid phenotype. Infect. Immun. 60 (1992) 1329-1335
34. Kaplan G. Differences in the mode of phagocytosis with Fc and C3 receptors in macrophages. Scand. J. Immunol. 6 (1977) 797-807
35. Isowa N., and Liu M. Role of LPS-induced microfilament depolymerization in MIP-2 production from rat pneumocytes. Am. J. Physiol. Lung Cell Mol. Physiol. 280 (2001) L762-L770
36. ACCP-NHLBI National Conference on Oxygen Therapy. Chest 86 (1984) 234-247
37. Standiford T.J., Wilkowski J.M., Sisson T.H., Hattori N., Mehrad B., Bucknell K.A., and Moore T.A. Intrapulmonary tumor necrosis factor gene therapy increases bacterial clearance and survival in murine gram-negative pneumonia. Hum. Gene Ther. 10 (1999) 899-909
38. Chen G.H., Reddy R.C., Newstead M.W., Tateda K., Kyasapura B.L., and Standiford T.J. Intrapulmonary TNF gene therapy reverses sepsis-induced suppression of lung antibacterial host defense. J. Immunol. 165 (2000) 6496-6503
39. Fidelus R.K., and Tsan M.F. Enhancement of intracellular glutathione promotes lymphocyte activation by mitogen. Cell. Immunol. 97 (1986) 155-163
40. Kalayjian R.C., Skowron G., Emgushov R.T., Chance M., Spell S.A., Borum P.R., Webb L.S., Mayer K.H., Jackson J.B., Yen-Lieberman B., et al. A phase I/II trial of intravenous L-2-oxothiazolidine-4-carboxylic acid (procysteine) in asymptomatic HIV-infected subjects. J. Acquir. Immune Defic. Syndr. 7 (1994) 369-374
41. Brown L.A., Harris F.L., and Guidot D.M. Chronic ethanol ingestion potentiates TNF-alpha-mediated oxidative stress and apoptosis in rat type II cells. Am. J. Physiol. Lung Cell Mol. Physiol. 281 (2001) L377-L386
42. Lee Y.C., Lee K.S., Park S.J., Park H.S., Lim J.S., Park K.H., Im M.J., Choi I.W., Lee H.K., and Kim U.H. Blockade of airway hyperresponsiveness and inflammation in a murine model of asthma by a prodrug of cysteine, L-2-oxothiazolidine-4-carboxylic acid. FASEB J. 18 (2004) 1917-1919
43. Danielson D.S., Heagy W., Nieman K.M., and West M.A. Relative hyperoxia augments lipopolysaccharide-stimulated cytokine secretion by murine macrophages. Surgery 133 (2003) 538-546
44. O'Brien-Ladner A.R., Nelson M.E., Cowley Jr. B.D., Bailey K., and Wesselius L.J. Hyperoxia amplifies TNF-alpha production in LPS-stimulated human alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 12 (1995) 275-279
45. Pepperl S., Dorger M., Ringel F., Kupatt C., and Krombach F. Hyperoxia upregulates the NO pathway in alveolar macrophages in vitro: role of AP-1 and NF-kappaB. Am. J. Physiol. Lung Cell Mol. Physiol. 280 (2001) L905-L913
46. Bautista A.P. Free radicals, chemokines, and cell injury in HIV-1 and SIV infections and alcoholic hepatitis. Free Radic. Biol. Med. 31 (2001) 1527-1532
47. Dalle-Donne I., Rossi R., Milzani A., Di Simplicio P., and Colombo R. The actin cytoskeleton response to oxidants: from small heat shock protein phosphorylation to changes in the redox state of actin itself. Free Radic. Biol. Med. 31 (2001) 1624-1632
48. Mirabelli F., Salis A., Marinoni V., Finardi G., Bellomo G., Thor H., and Orrenius S. Menadione-induced bleb formation in hepatocytes is associated with the oxidation of thiol groups in actin. Arch. Biochem. Biophys. 264 (1988) 261-269
49. 2+-dependent mechanisms. Arch. Biochem. Biophys. 270 (1989) 478-488
50. Bellomo G., Mirabelli F., Vairetti M., Iosi F., and Malorni W. Cytoskeleton as a target in menadione-induced oxidative stress in cultured mammalian cells. I. Biochemical and immunocytochemical features. J. Cell Physiol. 143 (1990) 118-128
51. Chiarugi P., Pani G., Giannoni E., Taddei L., Colavitti R., Raugei G., Symons M., Borrello S., Galeotti T., and Ramponi G. Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. J. Cell Biol. 161 (2003) 933-944
52. Fiaschi T., Cozzi G., Raugei G., Formigli L., Ramponi G., and Chiarugi P. Redox regulation of beta-actin during integrin-mediated cell adhesion. J. Biol. Chem. 281 32 (2006) 22983-22991
53. Milzani A., DalleDonne I., and Colombo R. Prolonged oxidative stress on actin. Arch. Biochem. Biophys. 339 (1997) 267-274
54. Milzani A., Rossi R., Di Simplicio P., Giustarini D., Colombo R., and DalleDonne I. The oxidation produced by hydrogen peroxide on Ca-ATP-G-actin. Protein Sci. 9 (2000) 1774-1782
55. Hayes J.D., and McLellan L.I. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic. Res. 31 (1999) 273-300
56. Dickinson D.A., and Forman H.J. Glutathione in defense and signaling: lessons from a small thiol. Ann. N. Y. Acad. Sci. 973 (2002) 488-504
57. Housset B., Hurbain I., Masliah J., Laghsal A., Chaumette-Demaugre M.T., Karam H., and Derenne J. Toxic effects of oxygen on cultured alveolar epithelial cells, lung fibroblasts and alveolar macrophages. Eur. Respir. J. 4 (1991) 1066-1075
58. Claiborne A., Yeh J.I., Mallett T.C., Luba J., Crane III E.J., Charrier V., and Parsonage D. Protein-sulfenic acids: diverse roles for an unlikely player in enzyme catalysis and redox regulation. Biochemistry 38 (1999) 15407-15416
59. Aerts C., Wallaert B., Gosset P., and Voisin C. Relationship between oxygen-induced alveolar macrophage injury and cell antioxidant defence. J. Appl. Toxicol. 15 (1995) 53-58
60. Bolm M., Chhatwal G.S., and Jansen W.T. Bacterial resistance of daf-2 mutants. Science 303 5666 (2004) 1976
61. Day B.J., van Heeckeren A.M., Min E., and Velsor L.W. Role for cystic fibrosis transmembrane conductance regulator protein in a glutathione response to bronchopulmonary pseudomonas infection. Infect. Immun. 72 (2004) 2045-2051